Seqirus
Flucelvax Quadrivalent (2021/2022)
Manufacturer:
Seqirus
Name:
Flucelvax Quadrivalent (2021/2022)
HCPCS Code Descriptor:
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use
Category:
CPT Drug Code
HCPCS:
90756
NDC(s):
70461-0422-10
Primary Type:
Vaccine-Flu
Generic Status:
Single-Source
Route of Administration:
Intramuscular
About:
Flucelvax Quadrivalent (2021/2022) is a Vaccine-Flu drug manufactured by Seqirus and administered via the Intramuscular route of administration. The CPT Drug Code: 90756 is aligned to the drug Flucelvax Quadrivalent (2021/2022).